Terbinafine, Fluconazole, and Itraconazole for Dermatophyte Toenail Onychomycosis
A novel study used network meta-analysis to compare pulse and continuous systemic therapies for toenail onychomycosis.
A novel study used network meta-analysis to compare pulse and continuous systemic therapies for toenail onychomycosis.
Outcomes of a proprietary topical therapy containing cantharidin for treatment of molluscum contagiosum is not affected by number of baseline lesions.
Biologic agents should be considered for treatment of patients with psoriasis comorbidities including depressive symptoms and coronary artery disease.
Some antihistamines may serve as potential monotherapy or adjunct therapy for alopecia areata.
An extension study finds that a novel topical minocycline foam is safe and well tolerated for the treatment of rosacea for up to 52 weeks.
Consistent efficacy outcomes of abrocitinib for the treatment of patients with moderate to severe atopic dermatitis were demonstrated in phase 3 and phase 2B studies.
One of the largest case series of intranasal butorphanol rescue therapy in treating intractable itch demonstrates success.
The use of spironolactone for alopecia was not associated with estrogen-dependent cancer recurrence.
A diagnosis of hidradenitis suppurativa was not found to be associated with a greater risk for stroke.
An evaluation of the safety and efficacy of a novel tazarotene topical for acne finds a possible new treatment option.